Mr. Rafael Cruz mena MD

Recommended Articles

• What Is Obsessive Compulsive Disorder?

  Obsessive compulsive disorder (OCD) is an anxiety disorder characterized by obsessive, unreasonable thoughts, and repetitive, compulsive behaviors. The recurring thoughts and fears, called obsessions, leads to the need to repetitively perform certain actions, called compulsions, that would help in...

• What Is Akathisia: Causes, Symptoms, and Treatment

  What is akathisia?Akathisia is a feeling of anxiety or restlessness. Its symptoms tend to overlap with the symptoms of other physical and psychological disorders. The diagnosis depends on a very subjective feeling of restlessness. Hence, recognizing akathisia can be somewhat tricky. Movement...

• What Is Celexa and Is It Safe During Pregnancy?

  Anxiety and depression are medical conditions associated with the brain. While the complexities of these conditions are highly intense, in simple language, they are referred to as chemical imbalances in the brain. The most common medications used when it comes to the treatment of depression and...

• What are the Treatment Methods for ADHD?

  Reported cases of ADHD have been on the rise lately. In fact, the U.S. Centers for Disease Control and Prevention reported that as many as 11% of children between the ages of four years old and 17 years old have been diagnosed with ADHD. ADHD is a disease characterized by ongoing patterns of...

• Adderall for ADHD: Does it Work?

  What is Adderall?Adderall is the brand name of a prescription drug that contains a mixture of amphetamine salts, specifically 75% dextroamphetamine salt and 25% levoamphetamine salt. It belongs to the drug class of central nervous system (CNS) stimulants. It is also classified among...

• Pristiq vs. Effexor

  Pristiq and Effexor are medications that have similar compositions and are produced by the same manufacturing company. Pristiq (desvenlafaxine) is an antidepressant, which has been recently approved by the FDA. The composition of Pristiq is similar to Wyeth’s existing antidepressant. The patent...